Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 12, 2024

https://www.prnewswire.com/news-releases/delcath-systems-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302033830.html

NEW YORK, Jan. 12, 2024 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as a material inducement to the employment of two individuals whose employment commenced in December 2023.  

Read more at prnewswire.com

Related news for (DCTH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.